Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease · SciRah

^aDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee , USA
^bSoutheastern National Tuberculosis Center, Division of Infectious Diseases and Global Medicine, Department of Medicine in the College of Medicine, University of Florida , Gainesville, Florida , USA
^cDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA
^dGeorgia State Tuberculosis Program , Atlanta, Georgia , USA
^eTranslational Research, College of Pharmacy and Emerging Pathogens Institute, University of Florida , Gainesville, Florida , USA
^fDepartment of Epidemiology, Rollins School of Public Health, Emory University , Atlanta, Georgia , USA
^gFairfax County Health Department , Annandale, Virginia , USA
^hNew Mexico Department of Health , Santa Fe, New Mexico , USA
ⁱNew Mexico Veterans Affairs Health Care System , Albuquerque, New Mexico , USA
^jUniversity of New Mexico School of Medicine , Albuquerque, New Mexico , USA
^kHumana Healthy Horizons in Kentucky , Louisville, Kentucky , USA
^lLouisville Metro Department of Public Health and Wellness , Louisville, Kentucky , USA
^mCurry International Tuberculosis Center, University of California , San Francisco, California , USA
ⁿPuerto Rico Department of Health , San Juan, Puerto Rico , USA
^oHealthPartners Institute , Bloomington, Minnesota , USA
^pSaint Paul–Ramsey County Public Health , Saint Paul, Minnesota , USA
^qDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington , Seattle, Washington , USA
^rDepartment of Medicine, Medical University of South Carolina , Charleston, South Carolina , USA
^sSouth Carolina Department of Health and Environmental Control , Greenville, South Carolina , USA
^tNew York City Department of Health and Mental Hygiene , Bureau of Tuberculosis Control, New York, New York , USA
^uSoutheastern National Tuberculosis Center, University of Florida , Gainesville, Florida , USA
^vDepartment of Pediatrics and Adolescent Medicine , Mayo Clinic, Rochester, Minnesota , USA
^wDepartment of Medicine, University of Washington, Seattle , Washington , USA
^xPublic Health—Seattle & King County , Seattle, Washington , USA
^yDepartment of Medicine, University of Washington, Seattle, Washington, USA
^zPulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, University of Washington , Seattle, Washington , USA
^aaCook County Department of Public Health , Forest Park, Illinois , USA
^abBureau of Public Health Laboratories , Florida State Tuberculosis Program, Jacksonville, Florida , USA
^acDivision of Infectious Diseases, Department of Medicine, NorthShore University HealthSystem , Evanston, Illinois , USA
^adJefferson County Department of Health , Birmingham, Alabama , USA
^aeDivision of Tuberculosis Elimination, Centers for Disease Control and Prevention, Puerto Rico Department of Health, San Juan , Puerto Rico , USA
^afAlabama Department of Public Health , Montgomery, Alabama , USA
^agGlobal Tuberculosis Institute, Rutgers University , Newark, New Jersey , USA
^ahMedical College of Wisconsin , Milwaukee, Wisconsin , USA
✉Corresponding author

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Abstract

Plain-language summary

Discussion